Cassandra Shu

Genesys (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index218citations6works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein purification and stability(3), Immunotherapy and Immune Responses(2), Virus-based gene therapy research(2), Viral Infectious Diseases and Gene Expression in Insects(2), Drug Solubulity and Delivery Systems(1)

Publications6 total

Hepatitis-B Surface Antigen (HBsAg) Powder Formulation: Process and Stability Assessment
Current Drug Delivery·2006· 20 cited
145. Detection of the Primary Destabilizing Modification of Liquid-Formulated Adenoviral Vectors by Anion-Exchange High Performance Liquid Chromatography
Molecular Therapy·2006Open Access
134. A Mechanistic and Kinetic Model for the Inactivation of Liquid-Formulated Adenoviral Vectors by the Delayed Onset of a Rapid Period of Penton Disassociation
Molecular Therapy·2006Open Access
Influenza Vaccine Powder Formulation Development: Spray‐Freeze‐Drying and Stability Evaluation
Journal of Pharmaceutical Sciences·2004· 113 cited
Optimization of an Alum-Adsorbed Vaccine Powder Formulation for Epidermal Powder Immunization
Pharmaceutical Research·2003· 24 cited
Adjuvantation of epidermal powder immunization
Vaccine·2001· 61 cited

Frequent Co-authors

Yuh‐Fun Maa(4), Lendon G. Payne(4), Dexiang Chen(4), Mahmoud Ameri(3), Cindy Zuleger(2), Jenny Che(2), Jorge E. Osorio(2), David Frey(2), Cherie A. Erickson(1), Ryan L. Endres(1), S. Bhargava Periwal(1), Qili Chu(1)